NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations
- 14 February 1991
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 193 (3) , 283-292
- https://doi.org/10.1016/0014-2999(91)90141-c
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- (R)-4-Oxo-5-phosphononorvaline: a new competitive glutamate antagonist at the NMDA receptor complexJournal of Medicinal Chemistry, 1990
- The Excitatory Amino Acid Receptors: Their Classes, Pharmacology, and Distinct Properties in the Function of the Central Nervous SystemAnnual Review of Pharmacology and Toxicology, 1989
- Potential use of drugs modulating 5HT activity in the treatment of anxietyGeneral Pharmacology: The Vascular System, 1988
- Pharmacological effects of MDL 11,939: A selective, centrally acting antagonist of 5‐HT2 receptorsDrug Development Research, 1988
- Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonistsSynapse, 1987
- 2-amino-7-phosphonoheptanoic acid (AP7) produces discriminative stimuli and anticonflict effects similar to diazepamLife Sciences, 1986
- BuspironeDrugs, 1986
- Distress vocalization in rat pups a simple screening method for anxiolytic drugsJournal of Pharmacological Methods, 1985
- Muscle relaxant action of excitatory amino acid antagonistsNeuroscience Letters, 1985
- Studies on the efficacy and depressant potential of muscle relaxants in miceDrug Development Research, 1982